Prognostic nomogram for hepatocellular carcinoma patients after transarterial chemoembolization based on des-γ-carboxy prothrombin reactivity and modified Response Evaluation Criteria in Solid Tumors

• Published in: Journal of cancer research and therapeutics Vol. 17; no. 3; pp. 707 - 714
• Main Authors: Zhao, Su-Ming, Qiu, Li-Wei, Zhao, Hui, Gu, Wei-Wei, Yang, Xiao-Hu, Gu, Zhu-Xing, Shi, Rong-Feng, Ni, Cai-Fang
• Format: Journal Article
• Language: English
• Published: India Wolters Kluwer India Pvt. Ltd 01.07.2021; Medknow Publications & Media Pvt. Ltd
• Subjects: Adult; Aged; Aged, 80 and over; Biomarkers - blood; Carcinoma, Hepatocellular - blood; Carcinoma, Hepatocellular - diagnosis; Carcinoma, Hepatocellular - mortality; Carcinoma, Hepatocellular - therapy; Chemoembolization; Chemoembolization, Therapeutic; Clinical decision making; Clinical Decision-Making - methods; Female; Humans; Liver cancer; Liver Neoplasms - blood; Liver Neoplasms - diagnosis; Liver Neoplasms - mortality; Liver Neoplasms - therapy; Male; Medical prognosis; Middle Aged; Nomograms; Protein Precursors - blood; Prothrombin; Response Evaluation Criteria in Solid Tumors; Retrospective Studies; overall survival; transarterial chemoembolization; modified Response Evaluation Criteria in Solid Tumors; Des-γ-carboxy prothrombin; hepatocellular carcinoma

Aims: The aim of this study was to construct a nomogram that will predict the overall survival (OS) of hepatocellular carcinoma (HCC) patients after transarterial chemoembolization (TACE). Materials and Methods: Imaging data, clinical characteristics, and serum des-γ-carboxy prothrombin (DCP) levels...